Starazolin BlueLight Protect

Nom de l'organisation

C.O.C. FARMACEUTICI S.R.L.

SRN

IT-MF-000019321

Statut du fabricant

Actif

16 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW999

  Do not use if there are visible particles and/or changes in the color of the solution.
• CW999

  It is necessary to report any serious incident occurred in relation to the device to the manufacturer and the Competent authority of the Member state in which you are established.
• CW262

  Product is for single patient use [EN].
• CW032

  Do not use the product after the expiry date indicated on the package [EN].
• CW999

  For external use, do not swallow.
• CW007

  Do not use the product if container is damaged or not perfectly closed when you open it for the first time [EN].
• CW999

  If you suffer from severe damage to the clear layer at the front of the eye (the cornea), phosphates may cause in very rare cases cloudy patches on the cornea due to calcium build-up during treatment.
• CW999

  Dispose of the product according to your local waste management regulations.
• CW275

  Consult your doctor before you use this product if you are pregnant or breast-feeding [EN].
• CW999

  During application, do not touch eye or any other surface with the container’s dispensing edge.
• CW999

  Do not use in case of known incompatibility towards any of the ingredients.
• CW999

  In case of side effects during use, interrupt the treatment and consult a doctor.
• CW999

  Keep out of the reach of children.
• CW999

  Do not try to tamper or disassemble the nozzle from the bottle.
• CW999

  Product is for ophthalmic use only.
• CW036

  No interactions with drugs or other eye drops are reported; however, leave at least 15 minutes between administrations of any other eye drops [EN].

Marché principal en Lituanie ; disponible dans 2 pays au total.

Dénomination commerciale

Starazolin BlueLight Protect

Code d'UDI-DI

08057729510848

Basic UDI-DI

803395976DT01DT007ZM

Numéro de référence/catalogue

DT/01/DT/007

Entité d'attribution

GS1

Catégorie de risque

Classe IIb

Législation applicable

MDR [Règlement (UE) 2017/745 relatif aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

—

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• Q0299OPHTHALMIC DEVICES - OTHER